Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.
Carolyn H Still,Carlos J. Rodriguez,Jackson T. Wright,Jackson T. Wright,Timothy E. Craven,Adam P. Bress,Glenn M. Chertow,Paul K. Whelton,Jeff Whittle,Barry I. Freedman,Karen C. Johnson,Capri G. Foy,Jiang He,John B. Kostis,James P. Lash,Carolyn F. Pedley,Roberto Pisoni,James R. Powell,Barry M. Wall +18 more
Reads0
Chats0
TLDR
Targeting a SBP goal of ≤ 120mm Hg compared to ≤ 140 mm Hg led to similar SBP control and was associated with similar benefits and risks among all racial ethnic groups, though NHBs required an average of ~0.3 more medications.About:
This article is published in American Journal of Hypertension.The article was published on 2018-01-01 and is currently open access. It has received 24 citations till now. The article focuses on the topics: Standard treatment.read more
Citations
More filters
Journal ArticleDOI
Hypertension and race/ethnicity.
Bradley Deere,Keith C. Ferdinand +1 more
TL;DR: Despite extensive epidemiological research, racial/ ethnic minorities remain at higher risk HTN-related morbidity and mortality, and translational efforts may address the differential impact of HTN in racial/ethnic minorities.
Journal ArticleDOI
Guideline-Driven Management of Hypertension: An Evidence-Based Update.
TL;DR: A review of the results of relevant observational studies, randomized clinical trials, and meta-analyses published between January 2018 and March 2021 can be found in this paper, where the authors present new information in each of these areas has the potential to increase hypertension awareness, treatment, and control which remain essential for the prevention of cardiovascular disease and mortality in the future.
Journal ArticleDOI
Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-Reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Trial (SPRINT).
Shreya Rao,Matthew W. Segar,Adam P. Bress,Pankaj Arora,Wanpen Vongpatanasin,Vijay Agusala,Utibe R. Essien,Adolfo Correa,Alanna A. Morris,James A. de Lemos,Ambarish Pandey +10 more
TL;DR: The findings suggest that extrinsic and structural societal factors, more than genetic ancestry, may be the major drivers of the well-established racial disparity in cardiovascular health associated with hypertension.
Journal ArticleDOI
Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK.
TL;DR: In this article, the authors identified factors associated with hypertension control among treated middle-aged UK adults, including older age, higher alcohol use, and race/ethnicity, and having ≥ 3 comorbidities.
Journal ArticleDOI
High blood pressure in Hispanics in the United States: a review.
TL;DR: Findings suggest significant screening and treatment disparities must be addressed to reduce HTN risk among the Hispanic population.
References
More filters
Journal ArticleDOI
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James,Suzanne Oparil,Barry L. Carter,William C. Cushman,Cheryl Dennison-Himmelfarb,Joel Handler,Daniel T. Lackland,Michael L. LeFevre,Thomas D. MacKenzie,Olugbenga Ogedegbe,Sidney C. Smith,Laura P. Svetkey,Sandra J. Taler,Raymond R. Townsend,Jackson T. Wright,Andrew S. Narva,Eduardo Ortiz +16 more
TL;DR: Although this guideline provides evidence-based recommendations for the management of high BP and should meet the clinical needs of most patients, these recommendations are not a substitute for clinical judgment, and decisions about care must carefully consider and incorporate the clinical characteristics and circumstances of each individual patient.
Journal ArticleDOI
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Dariush Mozaffarian,Emelia J. Benjamin,Alan S. Go,Donna K. Arnett,Michael J. Blaha,Mary Cushman,Sandeep R Das,Sarah D. de Ferranti,Jean-Pierre Després,Heather J. Fullerton,Virginia J. Howard,Mark D. Huffman,Carmen R. Isasi,Monik C. Jiménez,Suzanne E. Judd,Brett M. Kissela,Judith H. Lichtman,Lynda D. Lisabeth,Simin Liu,Rachel H. Mackey,David J. Magid,Darren K. McGuire,Emile R. Mohler,Claudia S. Moy,Paul Muntner,Michael E. Mussolino,Khurram Nasir,Robert W. Neumar,Graham Nichol,Latha Palaniappan,Dilip K. Pandey,Mathew J. Reeves,Carlos J. Rodriguez,Wayne D. Rosamond,Paul D. Sorlie,Joel M. Stein,Amytis Towfighi,Tanya N. Turan,Salim S. Virani,Daniel Woo,Robert W. Yeh,Melanie B. Turner +41 more
TL;DR: Author(s): Writing Group Members; Mozaffarian, Dariush; Benjamin, Emelia J; Go, Alan S; Arnett, Donna K; Blaha, Michael J; Cushman, Mary; Das, Sandeep R; de Ferranti, Sarah; Despres, Jean-Pierre; Fullerton, Heather J; Howard, Virginia J; Huffman, Mark D; Isasi, Carmen R; Jimenez, Monik C; Judd, Suzanne
Journal ArticleDOI
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
Curt D. Furberg,Jackson T. Wright,Barry R. Davis,Jeffrey A. Cutler,Michael H. Alderman,Henry R. Black,William C. Cushman,Richard H. Grimm,L. Julian Haywood,Frans H. H. Leenen,Suzanne Oparil,Jeffrey L. Probstfield,Paul K. Whelton,Chuke Nwachuku,David Gordon,Michael A. Proschan,Paula Einhom,Charles E. Ford,Linda B. Piller,I. Kay Dunn,David C. Goff,Sara L. Pressel,Judy Bettencourt,Barbara DeLeon,Lara M. Simpson,Joe Blanton,Therese S. Geraci,Sandra M. Walsh,Christine Nelson,Mahboob Rahman,Anne Juratovac,Robert Pospisil,Lillian Carroll,Sheila Sullivan,Jeanne Russo,Gail Barone,Rudy Christian,Sharon Feldman,Tracy Lucente,David A. Calhoun,Kim Jenkins,Peggy McDowell,Janice Johnson,Connie Kingry,Juan Alzate,Karen L. Margolis,Leslie Ann Holland-Klemme,Brenda Jaeger,Jeff D. Williamson,Gail T. Louis,Pamela Ragusa,Angela Williard,R. L Sue Ferguson,Joanna Tanner,John H. Eckfeldt,Richard S. Crow,John Pelosi +56 more
TL;DR: Thiazide-type diuretics are superior in preventing 1 or more major forms of CVD and are less expensive and should be preferred for first-step antihypertensive therapy.
Journal ArticleDOI
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Jackson T. Wright,Jeff D. Williamson,Paul K. Whelton,Joni K. Snyder,Kaycee M. Sink,Michael V. Rocco,David M. Reboussin,Mahboob Rahman,Mahboob Rahman,Suzanne Oparil,Cora E. Lewis,Paul L. Kimmel,Karen C. Johnson,David C. Goff,Lawrence J. Fine,Jeffrey A. Cutler,William C. Cushman,Alfred K. Cheung,Walter T. Ambrosius +18 more
TL;DR: In this article, the most appropriate targets for systolic blood pressure to reduce cardiovascular morbidity and mortality among persons without diabetes remain uncertain, and the authors propose a target of less than 120 mm Hg.
Journal ArticleDOI
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
C. Cushman,Gregory W. Evans,Robert P. Byington,Jeffrey A. Cutler,Denise G. Simons-Morton,Jan Basile,Jeffrey L. Probstfield,Lois A. Katz,Kevin A. Peterson,William T. Friedewald,John B. Buse,J. Thomas Bigger,Hertzel C. Gerstein +12 more
TL;DR: In patients with type 2 diabetes at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm HG, as compared with less than 140 mm Hg, did not reduce the rate of a composite outcome of fatal and nonfatal major cardiovascular events.
Related Papers (5)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Jackson T. Wright,Jeff D. Williamson,Paul K. Whelton,Joni K. Snyder,Kaycee M. Sink,Michael V. Rocco,David M. Reboussin,Mahboob Rahman,Mahboob Rahman,Suzanne Oparil,Cora E. Lewis,Paul L. Kimmel,Karen C. Johnson,David C. Goff,Lawrence J. Fine,Jeffrey A. Cutler,William C. Cushman,Alfred K. Cheung,Walter T. Ambrosius +18 more
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton,Robert M. Carey,Wilbert S. Aronow,Donald E. Casey,Karen J. Collins,Cheryl Dennison Himmelfarb,Sondra M. DePalma,Samuel S. Gidding,Kenneth Jamerson,Daniel W. Jones,Eric J. MacLaughlin,Paul Muntner,Bruce Ovbiagele,Sidney C. Smith,Crystal C. Spencer,Randall S. Stafford,Sandra J. Taler,Randal J. Thomas,Kim A. Williams,Jeff D. Williamson,Jackson T. Wright +20 more
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
Jeff D. Williamson,Mark A. Supiano,Mark A. Supiano,William B. Applegate,Dan R. Berlowitz,Dan R. Berlowitz,Ruth C. Campbell,Glenn M. Chertow,Larry J. Fine,William E. Haley,Amret T. Hawfield,Joachim H. Ix,Joachim H. Ix,Dalane W. Kitzman,John B. Kostis,Marie Krousel-Wood,Lenore J. Launer,Suzanne Oparil,Carlos J. Rodriguez,Christianne L. Roumie,Christianne L. Roumie,Ronald I. Shorr,Ronald I. Shorr,Kaycee M. Sink,Virginia G. Wadley,Paul K. Whelton,Jeff Whittle,Jeff Whittle,Nancy Woolard,Jackson T. Wright,Nicholas M. Pajewski +30 more